1. A Randomized, Controlled Comparison of NCX 470 (0.021%, 0.042%, and 0.065%) and Latanoprost 0.005% in Patients With Open-angle Glaucoma or Ocular Hypertension: The Dolomites Study. Issue 6 (6th June 2022) Authors: Walters, Thomas R.; Kothe, Angela C.; Boyer, José L.; Usner, Dale W.; Lopez, Krisol; Duquesroix, Brigitte; Fechtner, Robert D.; Navratil, Tomas Journal: Journal of glaucoma Issue: Volume 31:Issue 6(2022) Page Start: 382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma. (24th May 2018) Authors: Impagnatiello, Francesco; Bastia, Elena; Almirante, Nicoletta; Brambilla, Stefania; Duquesroix, Brigitte; Kothe, Angela C; Bergamini, Michael V W Journal: British journal of pharmacology Issue: Volume 176:Number 8(2019) Page Start: 1079 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗